faB's formation and development
The launch of FAB's new journal fulfills a dream envisioned by FAB's founders fifteen years ago. This initial issue provides a fitting opportunity to look back over FAB's past accomplishments, review the development of a distinctively feminist bioethics, and cast a glance over the terrain that lies ahead.
It happened this way: several of us were growing increasingly troubled by the tepid agenda and exclusionary practices of the burgeoning field of bioethics. Bioethical theory failed to take account of key components of moral life that structure the standpoints and experiences of women and other marginalized social groups including: physician/patient and researcher/subject relationships, power differences that mark these relationships, cross-cultural perspectives, and intersections between specific technological developments and the social, political, and economic structures in which they are embodied. Despite instances where the bioethical literature did chronicle patient abuse (the Tuskegee syphilis study, for instance), the dominant discourse implicitly endorsed the privilege of the powerful. Too frequently that discourse worked to legitimize the prevailing medical decision-making process and a research agenda that neglected the perspectives of women and minorities.
We sensed an acute need to develop new methodologies and strategies responsive to the disparate conditions of women's lives around the globe. One memorable day as Becky Holmes and I were commiserating about this sorry state, I mentioned the recent announcement of a new bioethics organization initiated by Peter Singer and Daniel Wikler, the International Association of Bioethics (IAB). They were inviting like-minded interest groups to affiliate with them. We jumped at this chance to organize a feminist bioethics community. I spoke with Wikler, and he offered to present to their board a formal proposal to establish a Network on Feminist Approaches to Bioethics. Following board approval, Becky Holmes and I set to work compiling a list of over seventy feminists who were writing and researching in fields related to bioethics. In July 1992, I sent invitations to them announcing the formation of a Network and a gathering at the inaugural IAB conference in Amsterdam. About sixty responded affirmatively, forming a core group of charter members. Though it was too late for many of them to attend the Congress in October, a few did and FAB was launched! Dutch women who joined us there have been a vital component of the Network ever since. The following month Boston area participants met with Becky and me to hear a brief report of the Congress, discuss the aims and scope of FAB, and outline an organizational structure. Becky and I served as coordinators during these initial years. 1 In 1994 we arranged a Women's Networking Luncheon at the "mega-meeting" of four bioethics societies (which soon became the American Society for Bioethics and Humanities (ASBH). We called another meeting at the Feminist
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Ethics and Social Policy Conference in Pittsburgh the same year. Fifteen FAB members presented papers there. It was at that gathering that the idea of a journal was first envisaged. Our immediate plans were more modest, however. Someone suggested that we initiate a FAB Listserv to stimulate cyberspace conversation. Corinne Bekker volunteered to be Listserv manager. From her base at the University of Utrecht, she guided a vital project that immeasurably enhanced communication among FAB members across the globe. Hilde Lindemann (Nelson) took the reins in 1999 and still holds them. FAB's voice was enhanced further by our newsletter, which launched its initial semi-annual issue in July 1993 under Rosemarie Tong's leadership. During the newsletter's initial four years, Becky Holmes struggled through the production process (with intermittent help from a few stalwarts) and members' voluntary contributions sustained printing and mailing expenses. Then in 1997, through the intervention of Margaret Little at the Kennedy Institute of Ethics, Georgetown University, the newsletter finally acquired much needed institutional support and a more professional format. Maggie also set up our Web site. In 1998, the newsletter moved to Charlotte, North Carolina, under Rosie Tong's care, and two years later it traveled to Michigan State University where it was facilitated by Hilde Lindemann. Then with volume 13 in 2005, the newsletter joined the digital age. Toby Schonfeld now produces a more detailed and accessible online version (www.fabnet.org).
In founding FAB we were determined that it should have a global reach. To implement that vision, members were recruited to act as "country representatives." The initial group represented The Netherlands, Canada, and Australia. One year later, representatives for Austria, India, New Zealand, and the United Kingdom were added. The list has increased apace: FAB now has representatives for twenty-two countries on six continents. To carry out the formidable task of keeping in touch with these representatives and soliciting their input on FAB policies, the position of Coordinator of Country Representatives was created in 1999. The position has been carried out with dedicated zeal, first by Wendy Rogers and then by Susana Sommer.
Becky and I served as co-coordinators until 1996 when an election was held at FAB's first international conference held in conjunction with the IAB Congress in San Francisco. It was the most intense concentration of feminist bioethicists ever gathered under a single roof. During our business meeting, we accomplished strenuous reorganizational work. Revised versions of a number of the papers presented there appeared in the first FAB anthology, Embodying Bioethics: Recent Feminist Advances, which I edited with Laura Purdy (Rowman and Littlefield 1998) . FAB has continued to hold biennial conferences in conjunction with IAB congresses. We are now laying plans for our seventh.
A team led by Gwen Anderson organized the program for FAB's second conference in 1998, immediately preceding the IAB World Congress in Tokyo. Thanks to the mediation of some of our international members, I was awarded a Ford Foundation grant to cover travel and accommodations for fifteen delegates from developing countries. For the first time, Euro-American speakers found themselves in the minority! Rosie Tong with Gwen Anderson and Aida Santos edited papers from this conference for the second FAB anthology, Globalizing Feminist Bioethics: Women's Health Concerns Worldwide (2001) .
In September 2000, Rosie organized the program for FAB's third conference, this time at Imperial College in London. One hundred and forty attendees from twenty-three countries heard papers presented by speakers from eighteen countries. Thanks to the superb IAB organization, the conference functioned smoothly and generated dynamic momentum even though it was more "Anglo" than the conference held in Japan. The editor of the journal Bioethics invited me to guest edit an issue comprised of a selection of papers based on FAB presentations (15:3, 2001 Representation at our 2004 conference in Sydney, Australia matched our London numbers. A volume based on that gathering will appear soon (Feminist Bioethics: At the Centre, on the Margins, ed. Jackie Leach-Scully, Laurel BaldwinRagaven, and Petya Fitzpatrick). In 2006, we went to Beijing. Highlights included plenary sessions presented by Chinese feminists and the IAB/FAB joint sessions. A selection of essays based largely on conference presentations appeared in Bioethics (21:9, 2007), which I edited with conference organizers Susan Dodds and Jing-Bao Nie (who has also published an anthology of Chinese views on abortion). Plans are now taking shape for our 2008 conference in Croatia.
FAB's relationship with the IAB continues to be mutually advantageous. Its officers and staff have organized the logistics for our conferences. And FAB members repeatedly have been elected to its board. Our members also have organized panels with explicit FAB themes at numerous interdisciplinary conferences includ-ing the World Congress on Medical Law (where FAB member Elisabeth Boetzkes Gedge won a best paper award), the American Public Health Association, and the International Association of Women Philosophers. FAB continues to organize events at major bioethics conferences in North America and abroad, including the Canadian Society for Bioethics and the American Society for Bioethics and Humanities.
From its inception, FAB's leadership has relied heavily on strongly committed members for expertise, critical judgment, and professional skills. But no formal advisory board existed until 1997, when some of FAB's long-term and most active members were invited to form one. The board, which is now elected by the members, has been of invaluable assistance to the coordinators both in implementing established policies and formulating new ones. The coordinators also are responsible for recruiting talent for the non-elective offices.
2 Until 2000, FAB had no written policies. Administrative decisions relied on personal memory and hearsay, for example, "this is how we did it last time." Then coordinator Rosie Tong insisted that FAB develop an institutional memory by committing policies to writing. Now even the old stalwarts, who feared that we were joining the ranks of the bureaucrats, are compelled to admit that the process of organizing explicit procedures has been a valuable exercise and absolutely essential to FAB's future.
At the start, no dues were required to join FAB, only completion of a written form indicating support of FAB's aims and goals. The original intent of the policy was to encourage membership of low-income scholars. But that policy constrained us, too. It meant that FAB's administrative expenses had to be covered primarily by the in-kind contributions of officers and members. And it left us without funds for travel grants to support participation of members from less prosperous countries in our conferences. So despite our non-elitist goals, we needed more reliable and less burdensome funding. To encourage cash donations, we applied for tax-exempt status (in the United States). For that purpose we needed a name, too. After groping for a fitting image, we decided on: "The Audre Lorde Memorial Fund for Bioethics Research." Why Audre Lorde? Because she had taught us so much through her courageous struggle to come to terms with her (ultimately fatal) illness, and she so fully exemplified the feminist ideal: to embody one's work in her lived experience. Then in 1997, the Kennedy Institute began to subsidize our newsletter. Its generous support gave us a much-needed breather. But our coffers were still slim because fewer than a third of our members ever contributed. So in 2002, when the Kennedy Institute terminated its support, and we could no longer lean on voluntary labor to maintain our membership list, we had to come to terms with our financial predicament. We reluctantly initiated a dues schedule and contracted with the Philosophy Documentation Center to maintain our membership roster. Beginning next year our publisher, Indiana University Press, will handle the membership list, collect dues (including subscriptions), and pass on voluntary contributions to the FAB treasurer. The future of our scholarship program will depend on the generosity of our members and supporters.
The expanding influence of feminist bioethics
I turn now from FAB's history to publications that spurred FAB's founding and the many FAB members who have since contributed. First, I must acknowledge the considerable debt all feminist bioethicists owe to those generations of women who preceded us-reaching back to the health care activists who predate the 1960s resurgence of feminism. The long history of women's interest in health care issues extends prior to the seizure of the practices of midwifery and nursing by the medical profession.
3 It was those historic influences that fed into the protest movements of the 1960s. That revival reinvigorated and extended longstanding concerns and directed attention to areas of health care where women's interests were neglected most severely-access to birth control and abortion, pregnancy, and representations of female sexuality. Then increasing medicalization and commodification of women's bodily functions intensified the need for vigilance and called attention to sexist biases in medical research and practice. Protest against the widespread exclusion of women from clinical trials, particularly in the United States, swelled momentum still further. Feminists in many countries campaigned for increased breast cancer research, more convenient and cheaper contraceptive methods, research on the physiology of menopause, and elimination of unnecessary surgical interventions, particularly hysterectomies, Caesarean sections, and radical mastectomies. Advocacy groups struggled to raise public awareness of women's health issues, influence health policy, and act as a counterforce to organized medicine and the pharmaceutical industry.
Feminist scholars began to complement the agendas of health care activists and some straddled both scholarly and activist communities. They documented the erosion of abortion access following the 1973 Roe v. Wade Supreme Court decision, and critiqued childbirth practices that sacrifice the interests of the birthing woman to the convenience of her obstetrician and the allegedly independent "right" of her fetus. By the 1980s, feminist bioethics scholarship was being widely circulated in feminist publications (e.g., Holmes, Hoskins, and Gross 1980, 1981; Corea 1985) . A sprinkling of this effort was surfacing in bioethics journals (e.g., Whitbeck 1981; Young 1984) . Feminist commentary on innovative reproductive interventions was burgeoning (e.g., Arditti, Klein, and Minden 1984; Corea 1985; Stanworth 1987) . Bioethics courses were proliferating and increasing the market for bioethics texts, but few included articles by feminists. Editors had a growing body of feminist literature on which to draw, but stereotypes persisted. Feminist approaches were often mistakenly assumed to address "women's concerns"-a special ethics for women. Where feminist contributions to the leading texts were included, they were confined principally to treatment of reproductive issuesabortion, maternal-fetal relations, and reproductive technologies. Interconnections between these issues and more pervasive bioethical concerns tended to be ignored.
The founding of FAB coincided with the appearance of a critical mass of feminist bioethics scholarship. In 1992, a collection of articles previously published in the journal Hypatia was brought out as Feminist Perspectives in Medical Ethics, edited by Becky Holmes and Laura Purdy. Susan Sherwin published No Longer Patient: Feminist Ethics and Health Care, the first book-length treatment of feminist bioethical theory (1992) . In this groundbreaking work, Sherwin expanded feminist bioethics in new directions that circumvent the prevalent theoretical approaches of the dominant bioethics framework and demonstrate its shortcomings. Volumes by Susan Bordo (1993) and Mary Mahowald (1993) critiqued medical and cultural attitudes toward women's bodies. Susan Wendell's The Rejected Body (1996) pressed this theme further showing how cultural attitudes toward the body contribute to the stigma of disability and denial of the body's inevitable weaknesses.
Soon bioethics think tanks and journals began to recognize feminist approaches. Several journals featured special issues by feminist scholars spanning a cluster of topics including AIDS, reconfiguration of the principle of autonomy, gender issues in psychiatry, and global dimensions of feminist bioethics. Bioethics conferences in a number of countries began to schedule sessions that explicitly addressed feminist bioethics, and more feminists were included in the general program. In 1994 bioethicists in China held the first of a series of conferences featuring feminist approaches. The Hastings Center also undertook a project in feminist ethics coordinated by FAB member Susan Wolf. Wolf, as many others in FAB, was concerned that although mainstream bioethicists included analyses of reproductive issues in their anthologies (where direct experience could not be disregarded), they neglected women's voices on other topics.
In her introduction to Feminism and Bioethics: Beyond Reproduction (1996), Wolf presents a strong argument to show how mainstream bioethics had been impoverished by ignoring feminist theory and perspectives.
By 1995, the wider bioethics community began to recognize the existence (and perhaps importance) of feminist perspectives. In March 1995, the Kennedy Institute of Ethics at Georgetown University entitled its annual Advanced Bioethics Course, "Feminist Perspectives on Bioethics." By the following year, mainstream journals had begun to take notice of feminist approaches. FAB members were invited to edit special issues of several journals on feminism and bioethics. However, the dearth of feminist representation on governmental panels formulating public policy has persisted, particularly in English-speaking countries. A group of Canadian feminists addressed this omission from the perspective of their own efforts to influence government policy. In an illuminating collection of essays, they relate their frustrations following the completion of projects funded by Canadian governmental agencies. They enumerate obstacles to implementation of published reports that hinder policy reforms and revamped practices (Sherwin 1998) .
More recent work has sought to bring increased attention to obstacles to policy reforms that could alleviate unjust burdens imposed predominantly on women. Both Jennifer Parks's No Place Like Home: Feminist Ethics and Home Health Care (2003) and Rosalind Ladd's anthology, Ethical Issues in Home Health Care (2002) address an issue of alarming proportions for the welfare of the aging, the home-bound, and those who risk their own economic security to care for them. They bring to their task much recent feminist work on both justice and care. Several other feminist bioethicists have joined the growing company of disability scholars who adapt features of care ethics conjoined with issues of justice to a range of themes intersecting disability (e.g., Parens and Asch 2000; Silvers, Wasserman, and Mahowald 1999, and Tremain 2005) .
Further care-related work branches off in other directions. Ruth Groenhout's Connected Lives: Human Nature and the Ethics of Care (2004) combines a care perspective with virtue theory. She teases out structural similarities between an ethics of care and bioethical theory to support a feminist approach that attends to the holistic nature of human persons, their particular social contexts, the centrality of emotional responses in ethical reasoning, and a refusal to judge actions apart from lived narratives that confer meaning on them. She emphasizes contexts in which social location and power imbalances figure prominently in the provision of care.
A related stream of feminist theorizing centers around the advantages of retaining within bioethics a conception of autonomy that is framed more robustly than the narrow interpretation common in the mainstream literature. Susan Sherwin and Susan Dodds point out respects in which the dominant conception fails to fit good medical practice. First, the standard view of autonomy gives no attention to details of personal experience, so individuals are treated as interchangeable. Sherwin points out that:
if we are to effectively address these concerns, we need to move away from the familiar Western understanding of autonomy as self-defining, self-interested, and self-protecting, as if the self were simply some special kind of property to be preserved. (1998, 35) Dodds emphasizes a consequence of the tendency among bioethicists and physicians to reduce autonomy to informed consent and restrict its exercise in medical practice to a patient's selection of choices from a restricted set of options (2000) . Standard formulations of the principle give inadequate attention to background conditions that patients bring to their medical experience and are insensitive to institutional power relationships that influence their health care options.
4 Both recognize that the options commonly available to patients, and their preferences, are constrained by multiple pressures including physician au-thority, power hierarchies within families, economic inequities, and other inequitable social arrangements. After the influence of such constraints is recognized, the need for a more nuanced conception of autonomy becomes obvious.
A number of suggestions have been put forward to reconceive autonomy in ways that would give fuller consideration to the agency of patients. Virginia Warren argues that this must be supplemented by an ethics of empowerment that gives patients access to a broader network informed by the work of feminist activists (2001) . Others would overhaul the conception more extensively and tailor other leading bioethical principles accordingly. This perspective shares with care theory the conviction that human agents are not fundamentally single-minded, rational, self-interested choice-makers but social beings, whose selfhood is constituted and maintained within overlapping relationships and communities. Recognizing the complexity of connection among individuals, their social milieu and their cultural matrix, some feminists now are calling for adoption of a relational model of autonomy that stresses the web of interconnected (and sometimes conflicting) relationships that shape and support individuality.
5
This direction of inquiry has been resourcefully extended by Carolyn McLeod (2002) . She elucidates a novel conception of self-trust within a feminist theoretical framework, thereby adding a new dimension to projects that aim to reframe the standard individualistic conception of autonomy in a way that illuminates its relational character. Drawing her illustrations principally from reproductive contexts including miscarriage, infertility treatment, and prenatal diagnosis, she shows how encounters with health care providers may undermine women's self-trust, thereby threatening their autonomy. She points out ways providers might reduce barriers to self-trust, and why respect for patient autonomy obligates them to be mindful of their power to influence patient self-trust. Her insightful analysis and well-chosen case histories invite extension of her conceptual innovations to other health care contexts. Her work, together with that of the other theorists on which she draws, illumines connections between autonomy and other bioethical principles and shows how they inform health-related practices.
future directions
I've included here only a sampling of the conceptual advances made by feminist bioethicists in recent years. Our new journal is the ideal vehicle to build on this base and initiate new directions. Volume two of IJFAB on Transnational Dialogues in Feminist Bioethics offers a splendid opportunity to explore uncharted territory, particularly where health and human rights intersect. Themes that re-quire fuller development include health-related dimensions of violence against women, both the everyday kinds of violence and the violence that accompanies the local wars that are proliferating around the globe. Both dimensions of violence inevitably exact a toll on the physical and mental health of victims. And both are clear violations of their human rights. A prominent example of everyday violence is the practice of genital cutting carried out on young girls. Many who have participated in discussions of this practice have hesitated to critique it because it is not integral to their own culture. But shifting the focus of attention from gender-specific oppression to human rights transforms the discussion. For human rights trumps toleration of cultural practices that violate bodily integrity.
Another glaring example of violations of bodily integrity that has transnational implications is the systematic rape of women in defeated territories by enemy troops. Survivors are bound to suffer from both health-related effects and lack of supportive relationships that could alleviate their suffering. Obviously needed are activist strategies that call attention to the trauma and misery of these women and their dependents. Important, too, are conceptual analyses that integrate the health consequences of these practices with related social effects including women's reduced access to the resources needed to restore their well-being and care for their children. For violence against women is not only about control over them but also about prevailing distributions of social power. Imbalances in the social power of groups lead to inequitable distribution of economic resources, which exacts a bitter toll on the less well off in both developing and developed countries (where, for example, the rates of maternal and infant mortality continue to rise). All of these violations raise human rights issues. Some of them have been integrated into human rights norms but more thorough and sensitive ethical analysis is needed that integrates the perceptiveness and cogency of feminist scholarship into human rights dialogue.
We ought not to neglect international dimensions of many other issues as well. Among those deserving much fuller exploration are gender disparities in the treatment of chronic disease (women receive less and are diagnosed later in disease progression), health research priorities (that often shortchange women), HIV/AIDS proliferation among women in the global South (in some sub-Saharan countries, sixty percent of AIDS sufferers are now women), and the health needs of migrants fleeing from war and famine to the West (where they often are short-changed by health care systems). Other issues calling for feminist perspectives include the encroachment of corporate interests on bioethics, including the propensity of pharmaceutical companies to co-opt physicians and bioethicists, the proliferation of institutional review boards that are beholden to commercial interests, and laws protecting patent holders who deny people access to their own genetic material.
These topics merely suggest a range of themes open to us. Many more will become evident as IJFAB embarks on a publishing venture which is bound to become an invaluable teaching and research tool to enrich both bioethics and feminism.
Summing up
So what has FAB accomplished in its initial fifteen years? We should take heart in the influence we have had on the development of feminist approaches. Through a shared vision and cross-fertilization of theoretical orientations, feminist bioethicists have brought fresh perspectives to bioethical theory and virtually all the major topics in bioethics. Their contributions are distinctive insofar as treatment of these topics is grounded in feminist scholarship that draws on background norms and prevailing conditions that shape health options. They have disputed the adequacy of abstract universal norms and the framework of allegedly universal moral principles that have dominated bioethical theory. They point out how the reigning approach, by focusing on a generic subject, privileges the perspective of an elite, mostly white male group, justifying the prevailing status quo and inhibiting consideration of constructive social change. They look toward a future when feminist thought has a more profound influence on bioethics, when the voices of the socially marginalized are more fully recognized, and the needs of all social groups are integrated into a system of health care justice that is responsive to the diverse needs of humans across the globe. The overriding vision of feminist bioethics is a nonhierarchical human community committed to mutual support and optimization of the health and well being of all. 
